Claritev Q1 revenue beats estimates, lifts 2026 outlook

Claritev

07/05/2026 11:10

Overview

US healthcare data platform's Q1 revenue rose 5.8%, beating analyst expectations

Q1 adjusted EBITDA increased 3.4% and slightly beat analyst expectations

Company raised 2026 revenue guidance, kept other outlook metrics unchanged

Outlook

Claritev raises 2026 revenue guidance to $985 mln-$1 bln from $980 mln-$1 bln

Company maintains 2026 Adjusted EBITDA guidance at $605 mln-$615 mln

Claritev expects continued growth from expansion into provider and government verticals

Result Drivers

CORE BUSINESS CONSISTENCY - Co said consistent performance in its core business drove Q1 revenue and adjusted EBITDA growth

EXPANSION INTO NEW VERTICALS - Co cited growth from expansion into provider and government verticals, leading to more diversified revenue streams

AI APPLICATIONS - Co said differentiated application of AI is helping accelerate progress and support growth

Company press release: ID:nBw6JTc60a

Key Details

Metric
Beat/Miss
Actual
Consensus Estimate
Q1 Revenue
Beat
$244.68 mln
$236.39 mln (3 Analysts)
Q1 Net Income
-$73.56 mln
Q1 Adjusted EBITDA
Slight Beat*
$146.90 mln
$145.50 mln (4 Analysts)
Q1 Operating Income
Miss
$6.64 mln
$17.77 mln (1 Analyst)
Q1 Pretax Profit
Miss
-$92.72 mln
-$91.01 mln (2 Analysts)

*Applies to a deviation of less than 1%; not applicable for per-share numbers.

For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.

(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)